CAS Medical appoints Patton as prez, CEO

Mary Stevens | August 30, 2010 | Health Exec | Precision Medicine

CAS Medical Systems (CASMED) has appointed Thomas M. Patton president, CEO and a member of its board of directors, effective Aug. 27.

Prior to joining CASMED, a Branford, Conn.-based developer of noninvasive patient monitoring technology, Patton served as the CEO of Wright Medical Group, an orthopedic device company in Memphis, Tenn.; and as President of Novametrix Medical Systems, a patient monitoring company in Wallingford, Conn.

Most recently, he acted as an advisor to the healthcare-focused private equity group of Ferrer Freeman & Company, and as CEO of QDx, a start-up developer of hematology diagnostics platform software.

Mary Stevens

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

CAS Medical appoints Patton as prez, CEO

Related Content

Around the web